Delivery Order SPE2DB25D3017-SPE2DB25FVJGQ
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90 tablets of Januvia 100 mg, valued at $13,040.09. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 5, 2025. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. Januvia is a prescription medication used in diabetes management, consistent with...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $40,455.90 by the Defense Logistics Agency (DLA) for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for 90 tablets of Januvia 100 mg by the Defense Logistics Agency (DLA) with a ceiling value of $2,224.88. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 7, 2025, and was awarded on May 6, 2025. This award carries no set-aside designation and represents a competitively awarded procurement. The delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,996.64 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract covers the supply of Januvia 50 mg tablets in a quantity of 90 units, utilizing firm fixed-price pricing. This award was issued competitively with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at approximately $25,949 by the Defense Logistics Agency (DLA) for the supply of Januvia 100 mg tablets (90-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded without set-aside restrictions. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,452.56 for 1,000 tablets of Januvia 100 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is a firm fixed price, non-set-aside delivery order issued by the Defense Department's Medical Supply Chain organization. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply delivery under the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,073.44 by the Defense Logistics Agency on September 10, 2025, with completion targeted for September 11, 2025. The order is for 90-count tablets of Januvia 50 mg, a pharmaceutical product for diabetes management, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award utilized firm fixed pricing with no set-aside designation, indicating competitive award to this qualified vendor...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,196.24 by the Defense Logistics Agency on August 21, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of August 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,091.46 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC)...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJGQDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 1,000 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract carries a ceiling value of $10,616.60 and was executed on May 30, 2025, with an ultimate completion date of June 2, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle valued through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio and demonstrated capability to meet open competition requirements have established it as a critical vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 5/30/25 |